Vimarsana
Biggest News Aggregation in the World

Page 3 - Pfizer Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Group Today - Breaking & Trending Today

Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon - Vimarsana News

Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon

On 23 June 2021 at its Investor Update, GSK plc (“GSK” or the “Company”) confirmed its intention to separate its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. It is proposed that the separation will be effected by way of a demerger (the “Demerger”) of ...

Q&A: enforcement of dominance rules in Indonesia - Vimarsana News

Q&A: enforcement of dominance rules in Indonesia

A look at how the competition authorities in Indonesia enforce provisions governing abuse of dominance, including sanctions, procedures and appeals.

£251m in de-risking deals as AIB converts APP, Wyeth seals buy-in - Vimarsana News

£251m in de-risking deals as AIB converts APP, Wyeth seals buy-in

Two de-risking deals for a combined £251m were announced today, comprising the first conversion of a Legal & General Assured Payment Policy and a buy-in

Source: ipe.com
Pfizer affiliate vaccinates U.K. plan with second buy-in - Vimarsana News

Pfizer affiliate vaccinates U.K. plan with second buy-in

Pfizer affiliate vaccinates U.K. plan with second buy-in BLOOMBERG Wyeth Group Pension and Life Assurance Scheme (1997), Sheffield, England, completed a £190 million ($268 million) buy-in with Aviva, confirmed Suthan Rajagopalan, risk transfer partner at Mercer. Mercer acted on behalf of the pension plan trustees. The deal covers just less than 50% of total liabilities. The £450 million pension fund, which is sponsored by Pfizer Group affiliate John Wyeth & Brother, has now insured close to all defined benefit liabilities through the latest buy-in and a £158 million risk transfer deal with...

Pfizer in talks with India over expedited approval for COVID-19 vaccine: CEO - Vimarsana News

Pfizer in talks with India over expedited approval for COVID-19 vaccine: CEO

ANI | Updated: May 03, 2021 14:38 IST New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India. "Unfortunately, our vaccine is not registered in India although our application was submitted months ago," Bourla, in a LinkedIn post, on Monday. "We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine a...

Source: aninews.in